Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 38893 entries
Sorted by: Best Match Show Resources per page
Severe, but manageable hypoxia caused by bronchospasm induced by bevacizumab.

Respirology case reports

Taniguchi H, Tsuchida T, Nakamura Y, Motoshima K, Mizoguchi K, Kohno S.
PMID: 25473529
Respirol Case Rep. 2013 Sep;1(1):14-6. doi: 10.1002/rcr2.10. Epub 2013 Aug 29.

Bevacizumab has a lower risk of treatment-related infusion reactions than other humanized monoclonal antibodies, and bronchospasm induced by bevacizumab has not been reported. We administered bevacizumab 15 mg/kg over 90 min infusion to a 34 year-old man with lung...

Cite
Taniguchi H, Tsuchida T, Nakamura Y, et al. Severe, but manageable hypoxia caused by bronchospasm induced by bevacizumab. Respirol Case Rep. 2013;1(1):14-6doi: 10.1002/rcr2.10.
Taniguchi, H., Tsuchida, T., Nakamura, Y., Motoshima, K., Mizoguchi, K., & Kohno, S. (2013). Severe, but manageable hypoxia caused by bronchospasm induced by bevacizumab. Respirology case reports, 1(1), 14-6. https://doi.org/10.1002/rcr2.10
Taniguchi, Hirokazu, et al. "Severe, but manageable hypoxia caused by bronchospasm induced by bevacizumab." Respirology case reports vol. 1,1 (2013): 14-6. doi: https://doi.org/10.1002/rcr2.10
Taniguchi H, Tsuchida T, Nakamura Y, Motoshima K, Mizoguchi K, Kohno S. Severe, but manageable hypoxia caused by bronchospasm induced by bevacizumab. Respirol Case Rep. 2013 Sep;1(1):14-6. doi: 10.1002/rcr2.10. Epub 2013 Aug 29. PMID: 25473529; PMCID: PMC4184640.
Copy Download .nbib Format: NLM
Seroprevalence of Herpes Simplex Virus Infection in HIV Coinfected Individuals in Eastern India with Risk Factor Analysis.

Advances in virology

Nag S, Sarkar S, Chattopadhyay D, Bhattacharya S, Biswas R, SenGupta M.
PMID: 26557849
Adv Virol. 2015;2015:537939. doi: 10.1155/2015/537939. Epub 2015 Oct 19.

Herpes simplex virus type 2 (HSV-2) is the cause of most genital herpes while HSV-1 is responsible for orolabial and facial lesions. In immunocompromised individuals, like HIV patients, impaired immunity leads to more frequent symptomatic and asymptomatic HSV infection....

Cite
Nag S, Sarkar S, Chattopadhyay D, et al. Seroprevalence of Herpes Simplex Virus Infection in HIV Coinfected Individuals in Eastern India with Risk Factor Analysis. Adv Virol. 2015;2015:537939doi: 10.1155/2015/537939.
Nag, S., Sarkar, S., Chattopadhyay, D., Bhattacharya, S., Biswas, R., & SenGupta, M. (2015). Seroprevalence of Herpes Simplex Virus Infection in HIV Coinfected Individuals in Eastern India with Risk Factor Analysis. Advances in virology, 2015537939. https://doi.org/10.1155/2015/537939
Nag, Soumyabrata, et al. "Seroprevalence of Herpes Simplex Virus Infection in HIV Coinfected Individuals in Eastern India with Risk Factor Analysis." Advances in virology vol. 2015 (2015): 537939. doi: https://doi.org/10.1155/2015/537939
Nag S, Sarkar S, Chattopadhyay D, Bhattacharya S, Biswas R, SenGupta M. Seroprevalence of Herpes Simplex Virus Infection in HIV Coinfected Individuals in Eastern India with Risk Factor Analysis. Adv Virol. 2015;2015:537939. doi: 10.1155/2015/537939. Epub 2015 Oct 19. PMID: 26557849; PMCID: PMC4628955.
Copy Download .nbib Format: NLM
Patient adherence and efficacy of certolizumab pegol in the management of Crohn's disease.

Clinical medicine insights. Gastroenterology

Blonski W, Buchner AM, Lichtenstein GR.
PMID: 24833930
Clin Med Insights Gastroenterol. 2012 Apr 10;5:11-21. doi: 10.4137/CGast.S7613. eCollection 2012.

Treatment with Anti-Tumor Necrosis Factor (anti-TNF) therapy has become a mainstay of therapy for patients with CD who are unresponsive to conventional medical management. Currently there are three anti-TNFα antibodies that have been approved by the US Food and...

Cite
Blonski W, Buchner AM, Lichtenstein GR. Patient adherence and efficacy of certolizumab pegol in the management of Crohn's disease. Clin Med Insights Gastroenterol. 2012;5:11-21doi: 10.4137/CGast.S7613.
Blonski, W., Buchner, A. M., & Lichtenstein, G. R. (2012). Patient adherence and efficacy of certolizumab pegol in the management of Crohn's disease. Clinical medicine insights. Gastroenterology, 511-21. https://doi.org/10.4137/CGast.S7613
Blonski, Wojciech, et al. "Patient adherence and efficacy of certolizumab pegol in the management of Crohn's disease." Clinical medicine insights. Gastroenterology vol. 5 (2012): 11-21. doi: https://doi.org/10.4137/CGast.S7613
Blonski W, Buchner AM, Lichtenstein GR. Patient adherence and efficacy of certolizumab pegol in the management of Crohn's disease. Clin Med Insights Gastroenterol. 2012 Apr 10;5:11-21. doi: 10.4137/CGast.S7613. eCollection 2012. PMID: 24833930; PMCID: PMC3987757.
Copy Download .nbib Format: NLM
Occupational asthma from exposure to rye flour in a Japanese baker.

Respirology case reports

Oshikata C, Tsurikisawa N, Saito A, Yasueda H, Akiyama K.
PMID: 25473582
Respirol Case Rep. 2014 Sep;2(3):102-4. doi: 10.1002/rcr2.63. Epub 2014 Jul 14.

Three years after beginning employment at a bakery, a 32-year-old Japanese man began experiencing acute asthma exacerbations after exposure to rye flour. Antigen-specific serum IgE antibodies were detected to the albumin and globulin, gliadin, prolamin, and glutenin protein fractions...

Cite
Oshikata C, Tsurikisawa N, Saito A, et al. Occupational asthma from exposure to rye flour in a Japanese baker. Respirol Case Rep. 2014;2(3):102-4doi: 10.1002/rcr2.63.
Oshikata, C., Tsurikisawa, N., Saito, A., Yasueda, H., & Akiyama, K. (2014). Occupational asthma from exposure to rye flour in a Japanese baker. Respirology case reports, 2(3), 102-4. https://doi.org/10.1002/rcr2.63
Oshikata, Chiyako, et al. "Occupational asthma from exposure to rye flour in a Japanese baker." Respirology case reports vol. 2,3 (2014): 102-4. doi: https://doi.org/10.1002/rcr2.63
Oshikata C, Tsurikisawa N, Saito A, Yasueda H, Akiyama K. Occupational asthma from exposure to rye flour in a Japanese baker. Respirol Case Rep. 2014 Sep;2(3):102-4. doi: 10.1002/rcr2.63. Epub 2014 Jul 14. PMID: 25473582; PMCID: PMC4184739.
Copy Download .nbib Format: NLM
The production of more useful monoclonal antibodies 2. The use of somatic-cell genetic and recombinant-DNA technology to tailor-make monoclonal antibodies.

Immunology today

Agulla HL, Pollock RR, Spira G, Scharff MD.
PMID: 25291336
Immunol Today. 1986 Dec;7(12):380-3. doi: 10.1016/0167-5699(86)90031-9.

In last month's issue(1) Matthew Scharff and his colleagues discussed recent improvements in the technique of making monoclonal antibodies by cell fusion. However, not all the monoclonal antibodies generated by hybridoma technology have all of the properties required for...

Cite
Agulla HL, Pollock RR, Spira G, et al. The production of more useful monoclonal antibodies 2. The use of somatic-cell genetic and recombinant-DNA technology to tailor-make monoclonal antibodies. Immunol Today. 1986;7(12):380-3doi: 10.1016/0167-5699(86)90031-9.
Agulla, H. L., Pollock, R. R., Spira, G., & Scharff, M. D. (1986). The production of more useful monoclonal antibodies 2. The use of somatic-cell genetic and recombinant-DNA technology to tailor-make monoclonal antibodies. Immunology today, 7(12), 380-3. https://doi.org/10.1016/0167-5699(86)90031-9
Agulla, H L, et al. "The production of more useful monoclonal antibodies 2. The use of somatic-cell genetic and recombinant-DNA technology to tailor-make monoclonal antibodies." Immunology today vol. 7,12 (1986): 380-3. doi: https://doi.org/10.1016/0167-5699(86)90031-9
Agulla HL, Pollock RR, Spira G, Scharff MD. The production of more useful monoclonal antibodies 2. The use of somatic-cell genetic and recombinant-DNA technology to tailor-make monoclonal antibodies. Immunol Today. 1986 Dec;7(12):380-3. doi: 10.1016/0167-5699(86)90031-9. PMID: 25291336.
Copy Download .nbib Format: NLM
Protein antigenicity: a static surface property.

Immunology today

Novotný J, Handschumacher M, Bruccoleri RE.
PMID: 25291494
Immunol Today. 1987;8(1):26-31. doi: 10.1016/0167-5699(87)90828-0.

Much recent progress has been made in understanding the nature of antigenicity in the generation of antibodies. In this article Jiří Novotný and his colleagues discuss properties such as accessibility, flexibility and shape which determine the antigenicity of sites...

Cite
Novotný J, Handschumacher M, Bruccoleri RE. Protein antigenicity: a static surface property. Immunol Today. 1987;8(1):26-31doi: 10.1016/0167-5699(87)90828-0.
Novotný, J., Handschumacher, M., & Bruccoleri, R. E. (1987). Protein antigenicity: a static surface property. Immunology today, 8(1), 26-31. https://doi.org/10.1016/0167-5699(87)90828-0
Novotný, J, et al. "Protein antigenicity: a static surface property." Immunology today vol. 8,1 (1987): 26-31. doi: https://doi.org/10.1016/0167-5699(87)90828-0
Novotný J, Handschumacher M, Bruccoleri RE. Protein antigenicity: a static surface property. Immunol Today. 1987;8(1):26-31. doi: 10.1016/0167-5699(87)90828-0. PMID: 25291494.
Copy Download .nbib Format: NLM
The biochemical basis of transmembrane signalling by B lymphocyte surface immunoglobulin.

Immunology today

Cambier JC, Monroe JG, Mark Coggeshall K, Ransom JT.
PMID: 25290184
Immunol Today. 1985 Jul;6(7):218-22. doi: 10.1016/0167-5699(85)90038-6.

The specificity of humoral immune responses is determined primarily at the level of antigen interaction with B lymphocytes which express antigen-specific receptor immunoglobulin. When receptor immunoglobulin is crosslinked by antigen or anti-receptor antibodies there isgeneration and transduction of signals...

Cite
Cambier JC, Monroe JG, Mark Coggeshall K, et al. The biochemical basis of transmembrane signalling by B lymphocyte surface immunoglobulin. Immunol Today. 1985;6(7):218-22doi: 10.1016/0167-5699(85)90038-6.
Cambier, J. C., Monroe, J. G., Mark Coggeshall, K., & Ransom, J. T. (1985). The biochemical basis of transmembrane signalling by B lymphocyte surface immunoglobulin. Immunology today, 6(7), 218-22. https://doi.org/10.1016/0167-5699(85)90038-6
Cambier, J C, et al. "The biochemical basis of transmembrane signalling by B lymphocyte surface immunoglobulin." Immunology today vol. 6,7 (1985): 218-22. doi: https://doi.org/10.1016/0167-5699(85)90038-6
Cambier JC, Monroe JG, Mark Coggeshall K, Ransom JT. The biochemical basis of transmembrane signalling by B lymphocyte surface immunoglobulin. Immunol Today. 1985 Jul;6(7):218-22. doi: 10.1016/0167-5699(85)90038-6. PMID: 25290184.
Copy Download .nbib Format: NLM
Usefulness of influenza vaccination during pregnancy to mothers and young infants.

Expert review of vaccines

Hisano M, Yamaguchi K.
PMID: 23002970
Expert Rev Vaccines. 2012 Aug;11(8):903-5. doi: 10.1586/erv.12.67.

As pregnant women are at increased risk of influenza infection and influenza-related complications, immunization with inactivated influenza vaccine during the influenza season is recommended. Vaccination during pregnancy is considered to provide benefits for both the mothers and their young...

Cite
Hisano M, Yamaguchi K. Usefulness of influenza vaccination during pregnancy to mothers and young infants. Expert Rev Vaccines. 2012;11(8):903-5doi: 10.1586/erv.12.67.
Hisano, M., & Yamaguchi, K. (2012). Usefulness of influenza vaccination during pregnancy to mothers and young infants. Expert review of vaccines, 11(8), 903-5. https://doi.org/10.1586/erv.12.67
Hisano, Michi, and Yamaguchi, Koushi. "Usefulness of influenza vaccination during pregnancy to mothers and young infants." Expert review of vaccines vol. 11,8 (2012): 903-5. doi: https://doi.org/10.1586/erv.12.67
Hisano M, Yamaguchi K. Usefulness of influenza vaccination during pregnancy to mothers and young infants. Expert Rev Vaccines. 2012 Aug;11(8):903-5. doi: 10.1586/erv.12.67. PMID: 23002970.
Copy Download .nbib Format: NLM
pH controlled staining of CD4(+) and CD19(+) cells within functionalized microfluidic channel.

Biomicrofluidics

Mortato M, Blasi L, Barbarella G, Argentiere S, Gigli G.
PMID: 24191176
Biomicrofluidics. 2012 Nov 05;6(4):44107. doi: 10.1063/1.4763560. eCollection 2012.

Herein proposed is a simple system to realize hands-free labeling and simultaneous detection of two human cell lines within a microfluidic device. This system was realized by novel covalent immobilization of pH-responsive poly(methacrylic acid) microgels onto the inner glass...

Cite
Mortato M, Blasi L, Barbarella G, et al. pH controlled staining of CD4(+) and CD19(+) cells within functionalized microfluidic channel. Biomicrofluidics. 2012;6(4):44107doi: 10.1063/1.4763560.
Mortato, M., Blasi, L., Barbarella, G., Argentiere, S., & Gigli, G. (2012). pH controlled staining of CD4(+) and CD19(+) cells within functionalized microfluidic channel. Biomicrofluidics, 6(4), 44107. https://doi.org/10.1063/1.4763560
Mortato, Mariangela, et al. "pH controlled staining of CD4(+) and CD19(+) cells within functionalized microfluidic channel." Biomicrofluidics vol. 6,4 (2012): 44107. doi: https://doi.org/10.1063/1.4763560
Mortato M, Blasi L, Barbarella G, Argentiere S, Gigli G. pH controlled staining of CD4(+) and CD19(+) cells within functionalized microfluidic channel. Biomicrofluidics. 2012 Nov 05;6(4):44107. doi: 10.1063/1.4763560. eCollection 2012. PMID: 24191176; PMCID: PMC3505194.
Copy Download .nbib Format: NLM
The effect of culture on the neuronotrophic activity of avian smooth muscle.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience

Abrahamson IK, Murdoch SY, Rush RA.
PMID: 24874037
Int J Dev Neurosci. 1984;2(3):229-39. doi: 10.1016/0736-5748(84)90017-0.

The expansor secundariorum is a smooth muscle of the chicken wing which receives a dense noradrenergic innervation and contains high concentrations of trophic activity for sympathetic neurons. Expansor cells were dissociated in trypsin and grown to confluency in standard...

Cite
Abrahamson IK, Murdoch SY, Rush RA. The effect of culture on the neuronotrophic activity of avian smooth muscle. Int J Dev Neurosci. 1984;2(3):229-39doi: 10.1016/0736-5748(84)90017-0.
Abrahamson, I. K., Murdoch, S. Y., & Rush, R. A. (1984). The effect of culture on the neuronotrophic activity of avian smooth muscle. International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience, 2(3), 229-39. https://doi.org/10.1016/0736-5748(84)90017-0
Abrahamson, I K, et al. "The effect of culture on the neuronotrophic activity of avian smooth muscle." International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience vol. 2,3 (1984): 229-39. doi: https://doi.org/10.1016/0736-5748(84)90017-0
Abrahamson IK, Murdoch SY, Rush RA. The effect of culture on the neuronotrophic activity of avian smooth muscle. Int J Dev Neurosci. 1984;2(3):229-39. doi: 10.1016/0736-5748(84)90017-0. PMID: 24874037.
Copy Download .nbib Format: NLM
The use of antibodies in the prophylaxis and treatment of infections.

Emerging microbes & infections

Lachmann PJ.
PMID: 26038423
Emerg Microbes Infect. 2012 Aug;1(8):e11. doi: 10.1038/emi.2012.2. Epub 2012 Aug 08.

The use of antibodies to provide passive immunity to infections has a long history. Although the coming of antibiotics greatly reduced its use for bacterial infections, it is still widely used for a variety of purposes which are reviewed...

Cite
Lachmann PJ. The use of antibodies in the prophylaxis and treatment of infections. Emerg Microbes Infect. 2012;1(8):e11doi: 10.1038/emi.2012.2.
Lachmann, P. J. (2012). The use of antibodies in the prophylaxis and treatment of infections. Emerging microbes & infections, 1(8), e11. https://doi.org/10.1038/emi.2012.2
Lachmann, Peter J. "The use of antibodies in the prophylaxis and treatment of infections." Emerging microbes & infections vol. 1,8 (2012): e11. doi: https://doi.org/10.1038/emi.2012.2
Lachmann PJ. The use of antibodies in the prophylaxis and treatment of infections. Emerg Microbes Infect. 2012 Aug;1(8):e11. doi: 10.1038/emi.2012.2. Epub 2012 Aug 08. PMID: 26038423; PMCID: PMC3630915.
Copy Download .nbib Format: NLM
The major albumin protein from pea (Pisum sativum L.) : Localisation by immunocytochemistry.

Planta

Harris N, Croy RR.
PMID: 24241226
Planta. 1985 Sep;165(4):522-6. doi: 10.1007/BF00398098.

The major albumin protein in storage parenchyma tissue of developing peas has been localised at an ultrastructural level by immunocytochemistry. Tissue was fixed in buffered aldehyde and embedded in LR White resin which was polymerised by addition of catalyst....

Cite
Harris N, Croy RR. The major albumin protein from pea (Pisum sativum L.) : Localisation by immunocytochemistry. Planta. 1985;165(4):522-6doi: 10.1007/BF00398098.
Harris, N., & Croy, R. R. (1985). The major albumin protein from pea (Pisum sativum L.) : Localisation by immunocytochemistry. Planta, 165(4), 522-6. https://doi.org/10.1007/BF00398098
Harris, N, and Croy, R R. "The major albumin protein from pea (Pisum sativum L.) : Localisation by immunocytochemistry." Planta vol. 165,4 (1985): 522-6. doi: https://doi.org/10.1007/BF00398098
Harris N, Croy RR. The major albumin protein from pea (Pisum sativum L.) : Localisation by immunocytochemistry. Planta. 1985 Sep;165(4):522-6. doi: 10.1007/BF00398098. PMID: 24241226.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 38893 entries